Reklama
twitter
youtube
facebook
instagram
linkedin
Reklama
Reklama

Sopharma AD: Notification for technical errors correction (2019-12-17)

|
selectedselectedselected
Reklama
Aa
Udostępnij
facebook
twitter
linkedin
wykop

UNI-EN 93:Notification for technical errors correction

Firma: SOPHARMA AD
Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Current report_93_correction_espi.pdf Notification for technical errors correction

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 93 / 2019
Date of issue: 2019-12-17
Short name of the issuer
SOPHARMA AD
Subject
Notification for technical errors correction
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Sofia, Bulgaria, December 17, 2019 - Sopharma AD (3JR: “BSE-Sofia” AD, SPH: Warsaw Stock Exchange) - Please apologize us for the following technical errors:

- In the Notification for treasury shares, published on December 11, 2019, please read the total number of treasury shares “8 906 832”, instead of “8 904 182”.
- In the Notification for treasury shares, published on December 13, 2019, please read number of shares “46 320”, instead of “41 320” and the total number of treasury shares “9 037 320”, instead of “9 032 320”.
- In the Notification for treasury shares, published on December 16, 2019, please read the text „Тhe Company bought 14 760 own shares representing 0.0109% of the share capital of the Company, at a total value of 50 922 BGN on the Bulgarian Stock Exchange, the average price per share was 3.45 BGN. The total number of treasury shares after this transaction is 9 052 080, representing 6.715% of the share capital of the Company“ ,instead of „Тhe Company bought 46 320 own shares representing 0.0344% of the share capital of the Company, at a total value of 159 693,26 BGN on the Bulgarian Stock Exchange, the average price per share was 3.4476 BGN. The total number of treasury shares after this transaction is 9 078 640, representing 6.74% of the share capital of the Company“.
- In the Notification for treasury shares, published on December 17, 2019, please read the total number of treasury shares “9 082 277” representing 6.738% of the share capital of the Company, instead of “9 108 837” representing 6.76% of the share capital of the Company.

We apologize for the inconvenience.
Annexes
File Description
Current report_93_correction_espi.pdf
Current report_93_correction_espi.pdf
Notification for technical errors correction

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2019-12-17 Ognian Donev Executive Director

Cena akcji Sopharma

Cena akcji Sopharma w momencie publikacji komunikatu to 9.8 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.

W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.

Jesteś dziennikarzem i szukasz pracy? Napisz do nas

Masz lekkie pióro? Interesujesz się gospodarką i finansami? Możliwe, że szukamy właśnie Ciebie.

Zgłoś swoją kandydaturę

Reklama